NIHR survey reveals public's attitudes to health research following coronavirus
A survey commissioned by the National Institute for Health Research (NIHR) to mark International Clinical Trials Day indicates that people’s attitudes towards pharmaceutical companies may have begun to change as a result of the pandemic.
The YouGov survey, published today, asked 2,023 respondents a range of questions on their understanding of coronavirus research - especially research in the UK - and the role it has played in tackling the pandemic.
The majority of the questions in the survey referred to 'all' health research; not specifying how it was funded. However, when specifically asked about commercial research, three in ten respondents interviewed (31%) expressed confidence (scoring 7+ on a scale 0 to 10) in taking part in health research funded by pharmaceutical companies, while nearly a fifth (18%) said they have more confidence than before as a result of vaccine delivery by companies such as AstraZeneca and Pfizer.